Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.65NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.75NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.18.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GL.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.78NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CR.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBKNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.14.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.69NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EY.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EL.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.44NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FU.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EF.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used